Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

FHS
May 27, 2024
1:08 am

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

Healthcare Groups Want Congress to Make Assaulting a Health Worker a Federal Crime

Mark Boucot has his signs ready. “The signs that will be hung around my facility [will] say ‘It is a federal crime to commit a

August 3, 2024

These Canadian LP Stocks Should Rally

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

August 22, 2024

Ahead of shareholder vote on SQZ asset sale and liquidation, founder Armon Sharei says he will vote yes

SQZ Biotechnologies shareholders are set to meet in two weeks to vote on the board’s recommendation that the company sell its assets to an old

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.